BCL2L2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.023200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.089640E-01
Normal-vs-Stage2
4.031000E-01
Normal-vs-Stage3
7.895000E-01
Normal-vs-Stage4
5.286200E-01
Stage1-vs-Stage2
5.971700E-02
Stage1-vs-Stage3
5.537600E-02
Stage1-vs-Stage4
3.991800E-01
Stage2-vs-Stage3
2.130000E-01
Stage2-vs-Stage4
8.540600E-01
Stage3-vs-Stage4
3.875200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.911000E-01
Normal-vs-AfricanAmerican
4.547400E-01
Normal-vs-Asian
7.238400E-01
Caucasian-vs-AfricanAmerican
9.007800E-01
Caucasian-vs-Asian
3.263000E-01
AfricanAmerican-vs-Asian
5.820200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.943800E-01
Normal-vs-Female
4.218000E-01
Male-vs-Female
9.410200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.350610E-01
Normal-vs-Age(41-60Yrs)
2.300200E-01
Normal-vs-Age(61-80Yrs)
5.331000E-01
Normal-vs-Age(81-100Yrs)
5.601800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.476800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.177000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.098160E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.462090E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.232170E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.365600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.586400E-01
Normal-vs-Daily Drinker
6.362200E-01
Normal-vs-Weekly Drinker
5.945000E-01
Normal-vs-Occasional Drinker
3.329800E-01
Normal-vs-Social Drinker
2.789600E-01
Non Drinker-vs-Daily Drinker
5.978000E-01
Non Drinker-vs-Weekly Drinker
7.898400E-01
Non Drinker-vs-Occasional Drinker
1.333800E-01
Non Drinker-vs-Social Drinker
1.195830E-01
Daily Drinker-vs-Weekly Drinker
8.628800E-01
Daily Drinker-vs-Occasional Drinker
8.650100E-02
Daily Drinker-vs-Social Drinker
7.764400E-02
Weekly Drinker-vs-Occasional Drinker
1.217980E-01
Weekly Drinker-vs-Social Drinker
1.090560E-01
Occasional Drinker-vs-Social Drinker
9.586200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.235000E-01
Normal-vs-Grade 2
1.467610E-01
Normal-vs-Grade 3
5.654000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.049800E-01
Grade 1-vs-Grade 3
2.794400E-01
Grade 1-vs-Grade 4
3.235000E-01
Grade 2-vs-Grade 3
6.487000E-01
Grade 2-vs-Grade 4
1.467610E-01
Grade 3-vs-Grade 4
5.654000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.126000E-01
Normal-vs-NonDiabetic
4.339200E-01
Diabetic-vs-NonDiabetic
8.534800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.622600E-01
Normal-vs-NoPancreatitis
4.596600E-01
Pancreatitis-vs-NoPancreatitis
7.093000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.712400E-01
Normal-vs-N1
4.298800E-01
N0-vs-N1
1.584990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.362800E-01
Normal-vs-TP53-NonMutant
4.007600E-01
TP53-Mutant-vs-TP53-NonMutant
7.196000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
